Recipharm, Cobra Biologics and Syntagon team up with five other companies in a new network to undertake the distortion of competition on the market. The new initiative is called LSIS, Life Science Innovation Support, and is formed to assure fair competition between private and public players. ThAlready a subscriber Login You…